Metabolism of isovanillin by aldehyde oxidase, xanthine oxidase, aldehyde dehydrogenase and liver slices.
Aromatic aldehydes are good substrates of aldehyde dehydrogenase activity but are relatively poor substrates of aldehyde oxidase and xanthine oxidase. However, the oxidation of xenobiotic-derived aromatic aldehydes by the latter enzymes has not been studied to any great extent. The present investigation compares the relative contribution of aldehyde dehydrogenase, aldehyde oxidase and xanthine oxidase activities in the oxidation of isovanillin in separate preparations and also in freshly prepared and cryopreserved liver slices. The oxidation of isovanillin was also examined in the presence of specific inhibitors of each oxidizing enzyme. Minimal transformation of isovanillin to isovanillic acid was observed in partially purified aldehyde oxidase, which is thought to be due to residual xanthine oxidase activity. Isovanillin was rapidly metabolized to isovanillic acid by high amounts of purified xanthine oxidase, but only low amounts are present in guinea pig liver fraction. Thus the contribution of xanthine oxidase to isovanillin oxidation in guinea pig is very low. In contrast, isovanillin was rapidly catalyzed to isovanillic acid by guinea pig liver aldehyde dehydrogenase activity. The inhibitor studies revealed that isovanillin was predominantly metabolized by aldehyde dehydrogenase activity. The oxidation of xenobiotic-derived aromatic aldehydes with freshly prepared or cryopreserved liver slices has not been previously reported. In freshly prepared liver slices, isovanillin was rapidly converted to isovanillic acid, whereas the conversion was very slow in cryopreserved liver slices due to low aldehyde dehydrogenase activity. The formation of isovanillic acid was not altered by allopurinol, but considerably inhibited by disulfiram. It is therefore concluded that isovanillin is predominantly metabolized by aldehyde dehydrogenase activity, with minimal contribution from either aldehyde oxidase or xanthine oxidase.
Panoutsopoulos
Georgios I
GI
Department of Pharmaceutical Chemistry, School of Pharmacy, University of Bradford, Bradford, UK. geopanou@otenet.gr
Beedham
Christine
C
D000444:Aldehyde Dehydrogenase / Q000378:metabolism*; D042931:Aldehyde Oxidase / Q000378:metabolism*; D000493:Allopurinol / Q000494:pharmacology; D000818:Animals; D001547:Benzaldehydes / Q000037:antagonists & inhibitors / Q000378:metabolism*; D015925:Cryopreservation / Q000379:methods; D004221:Disulfiram / Q000494:pharmacology; D006168:Guinea Pigs; D062385:Hydroxybenzoates / Q000037:antagonists & inhibitors / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D013997:Time Factors; D014641:Vanillic Acid / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000378:metabolism; D014969:Xanthine Oxidase / Q000378:metabolism*
D001547:Benzaldehydes; D062385:Hydroxybenzoates; C009091:protocatechuic acid; C093382:isovanillin; D000493:Allopurinol; C045317:isovanillic acid; D014969:Xanthine Oxidase; D000444:Aldehyde Dehydrogenase; D042931:Aldehyde Oxidase; D014641:Vanillic Acid; D004221:Disulfiram